Sally Pipes Talks COVID-19 Remdisivir Treatment on Alabama Morning News

Sally C. Pipes joined JT Nysewamder on Alabama Morning News in Birmingham to talk about the latest developments with the drug remdisivir. The drug, produced by Gilead, is being studied for potential use against COVID-19. Pipes and JT also discuss the cost of the drug, and how expensive it is to bring drugs to market in the United States.

Listen to the interview here. 

Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.

Scroll to Top